Septerna (SEPN) Revenue (2023 - 2026)

Septerna's quarterly Revenue came in at $26.5 million in Q1 2026, up 12000.46% year-on-year from N/an in Q1 2025, and up 9.88% quarter-over-quarter from $24.1 million in Q4 2025.

Septerna has reported Revenue for 4 years, with the latest figure at $26.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Revenue rose 12000.46% year-over-year to $26.5 million; the trailing twelve-month figure through Mar 2026 stood at $72.2 million (up 7293.24% YoY), and the FY2025 full-year result was $46.0 million, up 4174.51% from the prior year.
  • Revenue for Q1 2026 stood at $26.5 million, up from $24.1 million in the prior quarter.
  • The five-year high for Revenue was $26.5 million in Q1 2026, with the low at $33000.0 in Q3 2023.
  • Average Revenue over 4 years is $6.7 million, with a median of $219000.0 recorded in 2025.
  • Peak annual rise in Revenue reached 12113.07% in 2025, while the deepest fall reached 67.84% in 2025.
  • Tracing SEPN's Revenue over 4 years: stood at $118000.0 in 2023, then soared by 79.66% to $212000.0 in 2024, then surged by 11276.42% to $24.1 million in 2025, then advanced by 9.88% to $26.5 million in 2026.
  • The last three Revenue figures came in at $26.5 million (Q1 2026), $24.1 million (Q4 2025), and $21.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Septerna 1.34 Bn 1.34 Bn - 26.50 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 26.50 Mn
Dec 31, 2025 24.12 Mn
Sep 30, 2025 21.50 Mn
Jun 30, 2025 119,000.00
Mar 31, 2025 219,000.00
Dec 31, 2024 212,000.00
Sep 30, 2024 176,000.00
Jun 30, 2024 370,000.00
Mar 31, 2024 317,000.00
Dec 31, 2023 118,000.00
Sep 30, 2023 33,000.00